Abstract:Retroviral gene transfer is the method of choice for the stable introduction of genetic material into the cellular genome. However, efficient gene transfer is often limited by low transduction rates of the viral vectors. We have recently described a 12-mer peptide, termed EF-C, that forms amyloid-like peptide nanofibrils (PNF), strongly increasing viral transduction efficiencies. These nanofibrils are polycationic and bind negatively charged membranes of virions and cells, thereby overcoming charge repulsions and resulting in increased rates of virion attachment and gene transfer. EF-C PNF enhance vector transduction more efficiently than other soluble additives and offer prospects for clinical applications. However, while the transduction-enhancing activity of PNF has been well-characterized, the exact mechanism and the kinetics underlying infection enhancement as well as the cellular fate of the fibrils are hardly explored. This is partially due to the fact that current labeling techniques for PNF rely on amyloid probes that cause high background staining or lose signal intensities after cellular uptake. Here, we sought to generate EF-C PNF covalently coupled with fluorescent labels. To achieve such covalent bioconjugates, the free amino groups of the EF-C peptide were coupled to the ATTO 495 or 647N NHS ester dyes. When small amounts of the labeled peptides were mixed with a 100- to 10 000-fold excess of the native peptide, PNF formed that were morphologically indistinguishable from those derived from the unlabeled peptide. The fluorescence of the fibrils could be readily detected using fluorescence spectroscopy, microscopy, and flow cytometry. In addition, labeled and nonlabeled fibrils captured viral particles and increased retroviral transduction with similar efficacy. These covalently fluorescence-labeled PNF are valuable tools with which to elucidate the mechanism(s) underlying transduction attachment and the fate of the fibrils in cells, tissues, and animal models.

Study on capsid protein p Ⅸ genetically labeled by red fluorescent protein

Study on capsid protein p IX genetically labeled by red fluorescent protein

Random Insertion of Mcherry into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids with No Loss of Infectivity

Construction and Identification of Recombinant Adenovirus Expression VP1 of Foot and Mouth Disease Virus

Precision Fluorescent Labeling of an Adeno-Associated Virus Vector to Monitor the Viral Infection Pathway.

Construction and Identification of Recombinant Adenovirus Containing Human P27 Gene

Construction and Identification of the Adenoviral Vector with Dual Reporter Gene for Multimodality Molecular Imaging

Construction of Recombinant pDsRed-LC3 Fusion Protein and Its Expression and Localization in HepG2 Cell

Rapid Construction of AWP1-RFP Fused Gene Recombinant Adenovirus Vector and Its Identification

Construction and Identification of Recombinant Adenovirus Vector Expressing LacZ Gene

Construction of Recombinant Adenoviral Vector Co-Expressing Vascular Cell Adhesion Molecules-1 and Enhanced Green Fluorescent Protein

Generation of a pdmH1N1 2018 Influenza A Reporter Virus Carrying a mCherry Fluorescent Protein in the PA Segment

Construction of Recombinant Adenovirus Containing Chemerin Gene

Construction of Recombinant Adenovirus with Padxsi-Egfp-rnis and Initial Application

A Novel Adenovirus-Alphavirus Hybrid Vector

The Characterization of Modified Adenovirus Vector

[Construction and Identification of Recombinant Adenovirus Vector Expressing IkappaBalpha-IRES2-shCD40L].

Generation and Characterization of Virus-Enhancing Peptide Nanofibrils Functionalized with Fluorescent Labels

Genetically Engineered, Biarsenically Labeled Influenza Virus Allows Visualization of Viral Ns1 Protein in Living Cells

Construction and Immunological Characterizations of the Recombinant Adenovirus Expressing Multi-Genes of the FMDV Serotype O

Construction and verification of adenovirus containing the PUMA gene under the control of the hTER promoter